Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.800.700.640.790.98

What is the latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of BAFNA PHARMACEUTICALS is 0.80 based on Mar2026 Standalone results.
Year Fixed Capital/Sales
Mar20260.80
Mar20250.70
Mar20240.64
Mar20230.79
Mar20220.98

How is Fixed Capital/Sales of BAFNA PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.8
14.29
Mar2025 0.7
9.37
Mar2024 0.64
-18.99
Mar2023 0.79
-19.39
Mar2022 0.98 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹718.1 Cr 0.2% 13.2% 224.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,958.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,233.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹110,273.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.4 Cr 1.4% -3.7% -8.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

0.2%

13.2%

224.8%

SENSEX

-2.3%

-4.1%

-7.4%


You may also like the below Video Courses